Testing the validity and responsiveness of a new cancer-specific health utility measure (FACT-8D) in relapsed/refractory mantle cell lymphoma, and comparison to EQ-5D-5L.

Herdman, Michael; Kerr, Cicely; Pavesi, Marco; Garside, Jamie; Lloyd, Andrew; Cubi-Molla, Patricia; Devlin, Nancy

Herdman, Michael; Kerr, Cicely; Pavesi, Marco; Garside, Jamie; Lloyd, Andrew; Cubi-Molla, Patricia; Devlin, Nancy.

Afiliación

Herdman M; Office of Health Economics, Southside, 7th Floor, 105 Victoria Street, London, SW1E 6QT, UK. mherdman@ohe.org.
Kerr C; Janssen-Cilag Ltd, High Wycombe, UK.
Pavesi M; Data Management Centre, European Foundation for the Study of Chronic Liver Failure (EF-CLIF), Barcelona, Spain.
Garside J; Janssen-Cilag Ltd, High Wycombe, UK.
Lloyd A; Acaster Lloyd Consulting Ltd, London, UK.
Cubi-Molla P; Office of Health Economics, Southside, 7th Floor, 105 Victoria Street, London, SW1E 6QT, UK.
Devlin N; Office of Health Economics, Southside, 7th Floor, 105 Victoria Street, London, SW1E 6QT, UK.

J Patient Rep Outcomes ; 4(1): 22, 2020 Mar 27.

Article en En | MEDLINE | ID: mdl-32219576

Palabras clave

Cancer; Condition-specific non-preference-based measures; Generic preference-based measures; Quality of life; Utilities

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Aspecto: Patient_preference Idioma: En Revista: J Patient Rep Outcomes Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google